Split (1)

train · 9.11k rows

age float64 18 102	sex stringclasses 2 values	hospdead int64 0 1	slos int64 3 343	dzgroup stringclasses 8 values	dzclass stringclasses 4 values	num.co int64 0 9	edu float64 0 31 ⌀	income stringclasses 4 values	scoma float64 0 100 ⌀	charges float64 1.17k 1.44M ⌀	totcst float64 0 633k ⌀	totmcst float64 -102.72 711k ⌀	avtisst float64 1 83 ⌀	race stringclasses 5 values	sps float64 0.2 99.2 ⌀	aps float64 0 143 ⌀	surv2m float64 0 0.97 ⌀	surv6m float64 0 0.95 ⌀	hday int64 1 148	diabetes int64 0 1	dementia int64 0 1	ca stringclasses 3 values	prg2m float64 0 1 ⌀	prg6m float64 0 1 ⌀	dnr stringclasses 3 values	dnrday float64 -88 285 ⌀	meanbp float64 0 195 ⌀	wblc float64 0 200 ⌀	hrt float64 0 300 ⌀	resp float64 0 90 ⌀	temp float64 31.7 41.7 ⌀	pafi float64 12 890 ⌀	alb float64 0.4 29 ⌀	bili float64 0.1 63 ⌀	crea float64 0.1 21.5 ⌀	sod float64 110 181 ⌀	ph float64 6.83 7.77 ⌀	glucose float64 0 1.09k ⌀	bun float64 1 300 ⌀	urine float64 0 9k ⌀	adlp float64 0 7 ⌀	adls float64 0 7 ⌀	sfdm2 stringclasses 5 values	adlsc float64 0 7.07	event_times int64 3 2.03k	event_indicators int64 0 1
70.78198	female	0	20	ARF/MOSF w/Sepsis	ARF/MOSF	4	12	under $11k	0	29,158	14,752.7422	16,568.5469	16.666656	white	13.898438	20	0.899902	0.863892	1	1	0	no	0.5	0.5	no dnr	20	73	11.298828	80	20	37.79688	null	null	0.399963	1	138	null	130	19	null	1	0	<2 mo. follow-up	0	31	1
82.034	female	1	10	ARF/MOSF w/Sepsis	ARF/MOSF	1	8	null	9	27,756	7,517.25	23,028.2188	23	black	33.898438	76	0.407959	0.28894	4	0	0	no	0.5	0.4	dnr after sadm	2	66	6.399414	70	40	36.09375	80	2.699707	0.5	3.399902	138	7.439453	247	85	860	null	5	<2 mo. follow-up	5	10	1
82.55396	female	1	18	ARF/MOSF w/Sepsis	ARF/MOSF	1	14	null	0	58,079	57,121.4375	53,527.0312	26.666656	white	33.796875	68	0.416992	0.297974	9	0	1	no	0.9	0.75	dnr after sadm	10	107	7.699219	80	24	38	null	null	null	1	135	null	275	16	975	null	null	<2 mo. follow-up	5.213867	18	1
84.01898	male	0	3	CHF	COPD/CHF/Cirrhosis	4	14	$25-$50k	0	3,200	1,747.9268	1,724.50977	null	white	18.097656	34	0.822998	0.711914	1	0	0	no	0.9	0.8	no dnr	3	100	11.099609	100	20	37	null	null	null	0.599976	136	null	172	11	null	null	null	no(M2 and SIP pres)	2.732422	887	1
80.02698	female	0	18	COPD	COPD/CHF/Cirrhosis	3	12	null	0	29,207	11,660.3984	22,357.7344	24.333328	white	28.199219	40	0.5979	0.407959	2	0	0	no	0.6	0.6	no dnr	18	103	33	60	15	37	null	3.099609	1.5	0.799927	152	7.539062	176	13	54.5	0	0	no(M2 and SIP pres)	0	792	1
75.31598	female	0	30	Coma	Coma	0	12	under $11k	100	34,680	20,164.875	27,403.6406	17.5	black	14.798828	19	0.368958	0.295959	1	0	0	no	0.25	0.1	dnr after sadm	2	57	11.599609	80	20	37.29688	null	null	1.199951	1.199951	133	null	328	23	null	null	1	adl>=4 (>=5 if sur)	1	68	1
76.487	male	0	12	Cirrhosis	COPD/CHF/Cirrhosis	5	15	null	9	17,185	9,153.4531	8,645.51562	9	white	14.099609	28	0.708984	0.547974	1	0	0	yes	0.75	0.6	dnr after sadm	1	57	2.599609	114	32	37.79688	null	3.299805	4.599609	2.199707	135	null	98	31	350	null	0	SIP>=30	0	78	1
68.97998	male	0	3	COPD	COPD/CHF/Cirrhosis	6	12	under $11k	0	4,894	2,226.7188	2,818.84961	null	white	14.398438	34	0.872925	0.789917	1	0	0	yes	0.8	0.75	no dnr	3	83	14.5	100	25	36.09375	null	2.699707	null	0.899902	135	null	157	24	null	1	2	SIP>=30	2	387	1
67.45795	female	0	8	Lung Cancer	Cancer	1	14	under $11k	0	8,469	4,488.4531	6,305.9375	12.5	white	23	26	0.56189	0.238983	1	0	0	metastatic	0.3	0.1	no dnr	8	99	26.898438	68	20	37.69531	281.625	3	0.5	0.899902	141	7.269531	171	20	null	0	0	SIP>=30	0	121	1
64.30096	female	0	5	Colon Cancer	Cancer	2	16	>$50k	0	5,613	3,166.1211	715.5498	13	white	27.5	15	0.625	0.311951	1	0	0	metastatic	0.9	0.6	no dnr	5	49	13.599609	121	36	37.69531	316.625	3.199707	3.299805	5.099609	145	7.379883	155	8.798828	860	0	0	no(M2 and SIP pres)	0	1,020	0
87.25299	female	0	14	COPD	COPD/CHF/Cirrhosis	1	12	null	0	22,466	10,451.4688	14,536.5156	10	white	18.296875	29	0.743896	0.5979	2	0	0	no	0.75	0.7	no dnr	14	60	13.699219	120	44	38.19531	231.65625	null	0.599976	1.099854	150	7.329102	233	23	1,166	0	0	SIP>=30	0	1,006	1
73.92694	male	0	9	CHF	COPD/CHF/Cirrhosis	6	16	under $11k	0	14,982	7,797.0742	8,092.72656	7.5	white	26.199219	45	0.740967	0.592896	1	0	0	no	0.76	0.6	dnr before sadm	-1	73	9.699219	65	8	38.59375	122.5	null	null	1.399902	143	7.179688	265	36	1,005	2	0	SIP>=30	0	93	1
81.85095	male	0	20	ARF/MOSF w/Sepsis	ARF/MOSF	1	12	under $11k	0	52,814	30,049.1719	36,880.8438	40.666657	white	43.296875	59	0.241974	0.139984	1	0	0	no	0.1	0.05	no dnr	20	47	9.599609	70	24	37.89844	162.84375	1.899902	null	0.699951	139	7.319336	178	19	1,255	null	0	no(M2 and SIP pres)	0	726	1
72.52594	female	0	26	ARF/MOSF w/Sepsis	ARF/MOSF	1	null	null	0	64,956	24,196.6562	35,415.6875	27	black	30.5	22	0.655884	0.557983	1	1	0	no	0.02	0	no dnr	26	55	9.898438	112	40	38.19531	165.28125	4.199219	0.599976	1.099854	136	7.30957	282	24	1,930	null	0	adl>=4 (>=5 if sur)	0	1,018	0
72.35895	male	0	20	ARF/MOSF w/Sepsis	ARF/MOSF	2	12	null	0	33,427	13,770.5	28,687.7031	18.666656	white	17.398438	25	0.855957	0.805908	2	0	0	no	0.8	0.8	no dnr	20	109	10.599609	82	20	37.79688	373.3125	2.399902	0.899902	1.199951	141	7.399414	101	28	2,350	0	0	no(M2 and SIP pres)	0	446	1
83.49896	male	1	8	ARF/MOSF w/Sepsis	ARF/MOSF	1	16	>$50k	9	30,052	14,490.6094	14,161.5469	15	white	34.09375	72	0.366943	0.248993	1	0	0	yes	0.2	0.1	dnr after sadm	1	111	7	58	28	33.79688	388	2.399902	4.5	5.5	135	7.25	80	56	48	null	2	<2 mo. follow-up	2	8	1
77.35797	male	0	8	MOSF w/Malig	ARF/MOSF	2	12	>$50k	0	12,651	5,684.1094	5,677.72656	19	white	27.898438	34	0.588989	0.47998	1	1	0	yes	0.9	0.9	no dnr	8	57	6.099609	120	40	37.69531	94	null	null	1.399902	148	7.379883	140	66	758	0	2	no(M2 and SIP pres)	2	1,015	0
61.81198	female	0	20	COPD	COPD/CHF/Cirrhosis	4	12	under $11k	0	48,864	32,935.75	33,247.5312	28.666656	white	27.097656	41	0.792969	0.666992	1	1	0	no	0.9	0.85	no dnr	20	107	3.899902	60	20	36.69531	447.5625	4.099609	null	5.099609	138	7.379883	79	42	1,850	null	2	no(M2 and SIP pres)	2	1,015	0
85.172	male	1	4	MOSF w/Malig	ARF/MOSF	2	20	>$50k	0	12,742	8,474.7344	7,543.33984	36	white	36.195313	69	0.337952	0.221985	1	0	0	yes	0.05	0	dnr before sadm	-1	66	17.398438	120	33	37.69531	135	3.199707	null	1.299805	140	7.449219	118	43	1,340	null	null	<2 mo. follow-up	2.780762	4	1
77.63995	male	1	7	ARF/MOSF w/Sepsis	ARF/MOSF	2	null	null	100	19,449	6,839.2773	15,846.9766	19	black	24.5	49	0.256958	0.151978	3	1	0	no	null	null	dnr after sadm	6	100	null	80	30	39.39844	null	null	null	null	140	null	null	null	600	null	null	<2 mo. follow-up	3.683594	7	1
69.33899	male	0	16	ARF/MOSF w/Sepsis	ARF/MOSF	1	14	$11-$25k	0	54,183	16,196.5078	42,575	39.666657	white	27	39	0.702881	0.612915	4	0	0	no	0.5	0.5	no dnr	16	103	5.599609	80	20	37.79688	423.75	2.199707	1.799805	1.299805	145	7.469727	109	26	500	null	1	<2 mo. follow-up	1	23	1
35.116	male	1	13	ARF/MOSF w/Sepsis	ARF/MOSF	3	20	under $11k	0	38,566	14,847.1406	34,751.5	31	black	26.699219	43	0.860962	0.81189	1	0	0	no	0.8	0.8	dnr after sadm	4	76	6.899414	72	26	36.5	304	3.699707	null	1.099854	143	7.469727	96	10	1,490	null	6	<2 mo. follow-up	6	13	1
91.93396	female	1	15	ARF/MOSF w/Sepsis	ARF/MOSF	0	15	under $11k	44	95,204	62,915.8125	57,928.5	35	white	32	58	0.163971	0.081985	17	0	0	no	0.15	0.1	dnr after sadm	1	65	6.299805	108	26	37.09375	146.9375	null	null	null	140	7.329102	96	17	1,800	null	2	<2 mo. follow-up	2	15	1
81.29999	female	0	7	COPD	COPD/CHF/Cirrhosis	2	6	under $11k	0	7,211	4,100.0664	4,032.4082	5	white	20.097656	34	0.772949	0.637939	1	0	0	no	0.5	0.5	dnr after sadm	1	83	2.399902	60	20	36.29688	null	2.5	1.099854	0.899902	141	null	89	4	950	null	null	SIP>=30	3.75293	1,011	0
57.61298	female	0	4	Lung Cancer	Cancer	1	14	>$50k	0	13,214	6,605.2031	2,559.75977	16	white	12.199219	5	0.804932	0.583984	1	0	0	metastatic	0.9	0.7	no dnr	4	101	18.296875	69	20	36.29688	249	3.899902	null	1.5	140	7.179688	203	47	2,650	0	null	no(M2 and SIP pres)	0.494751	772	1
83.74799	female	0	5	COPD	COPD/CHF/Cirrhosis	4	12	under $11k	0	5,225	2,941.1777	3,058.41992	12	white	17.699219	31	0.744995	0.598999	1	0	0	yes	0.8	0.5	no dnr	5	67	17	100	25	36.39844	264	3.399902	1.099854	2.599609	136	7.429688	145	77	null	0	null	no(M2 and SIP pres)	0.494751	951	1
81.50897	male	0	17	ARF/MOSF w/Sepsis	ARF/MOSF	2	17	>$50k	9	23,306	12,391.3984	14,378.75	12.333328	white	20.398438	38	0.777954	0.706909	1	0	1	no	0.75	0.75	no dnr	17	37	8.398438	56	8	38.59375	63	3.099609	1.299805	2.199707	136	7.339844	109	37	1,530	null	6	adl>=4 (>=5 if sur)	6	1,007	0
74.26697	male	0	19	COPD	COPD/CHF/Cirrhosis	4	8	under $11k	0	26,839	13,803.5078	17,275.8594	12	white	19	36	0.831909	0.724976	1	0	0	no	0.8	0.8	no dnr	19	43	6.099609	105	8	38.39844	317.5	null	0.399963	0.5	147	7.399414	276	10	2,975	0	null	adl>=4 (>=5 if sur)	0.494751	199	1
75.98596	male	0	39	Lung Cancer	Cancer	2	null	null	0	51,147	27,488.625	29,141.6875	10	white	7.399414	20	0.837891	0.645996	1	0	0	metastatic	0.9	0.6	dnr after sadm	26	110	8.5	60	36	38.89844	254	2.799805	null	0.799927	134	7.419922	120	16	2,400	null	null	null	2.621094	122	1
87.59497	female	1	23	COPD	COPD/CHF/Cirrhosis	3	12	under $11k	0	53,912	18,908.0312	41,129.9062	23.333328	white	14.099609	29	0.820923	0.708984	1	0	0	no	0.5	0.2	no dnr	23	56	0.699951	102	30	39.19531	251.65625	null	1	2.399902	135	7.5	93	44	780	null	7	<2 mo. follow-up	7	23	1
80.77197	female	0	9	COPD	COPD/CHF/Cirrhosis	3	12	under $11k	0	12,938	6,714.7852	7,052.87891	10.5	white	16.398438	21	0.828979	0.721924	1	0	0	no	0.9	0.7	no dnr	9	55	4.699219	55	38	35.19531	280	3.399902	0.799927	0.899902	139	7.539062	196	10	2,050	1	0	SIP>=30	0	248	1
79.36499	female	0	10	ARF/MOSF w/Sepsis	ARF/MOSF	1	12	under $11k	0	15,161	11,720.0547	12,239.0781	16	white	19.898438	31	0.816895	0.755981	1	0	0	no	0.4	0.3	dnr after sadm	1	63	15.298828	60	8	37.79688	68.75	null	2	1.199951	135	7.439453	213	47	2,500	null	null	<2 mo. follow-up	2.866699	39	1
42.98199	male	0	8	CHF	COPD/CHF/Cirrhosis	3	16	>$50k	0	8,715	4,783.1445	5,150.4375	10.5	white	29.5	43	0.819946	0.707886	1	0	0	no	0.9	0.75	no dnr	8	58	2.299805	134	40	39.09375	484	null	null	3.699707	136	7.439453	80	108	1,935	1	2	<2 mo. follow-up	2	50	1
51.64999	female	0	14	ARF/MOSF w/Sepsis	ARF/MOSF	0	12	null	0	33,418	11,204.1328	26,288.0469	22.666656	white	25.097656	37	0.833984	0.777954	1	0	0	no	0.9	0.9	no dnr	14	52	10.599609	70	8	38.09375	196	2.299805	null	1.899902	145	7.429688	315	37	1,610	null	0	no(M2 and SIP pres)	0	1,004	0
78.64496	female	0	8	Colon Cancer	Cancer	2	12	null	0	7,249	4,118.5742	5,068.64844	2	white	15.099609	11	0.817993	0.60791	1	1	0	metastatic	0.8	0.4	no dnr	8	65	12.5	150	14	35.39844	null	null	0.799927	1.699951	144	null	145	21	4,345	0	1	adl>=4 (>=5 if sur)	1	1,003	0
55.48297	male	0	4	Lung Cancer	Cancer	1	12	>$50k	0	15,966	8,098.7812	3,559.55859	14	white	15.099609	5	0.763916	0.513916	1	0	0	metastatic	0.95	0.6	no dnr	4	142	15.099609	50	24	36.19531	null	2.199707	1.899902	3.099609	141	null	167	46	1,990	null	null	no(M2 and SIP pres)	1.988281	692	1
39.784	female	1	5	ARF/MOSF w/Sepsis	ARF/MOSF	2	12	$11-$25k	0	23,300	8,672.8906	14,412.8594	52	white	35.796875	77	0.709961	0.621948	1	0	0	no	0.5	0.5	no dnr	5	73	22.597656	110	14	36.69531	190	1.399902	null	4	129	7.369141	77	62	1,460	null	0	<2 mo. follow-up	0	5	1
68.31195	female	1	10	CHF	COPD/CHF/Cirrhosis	3	9	under $11k	9	11,437	6,671.9297	6,360.73828	16.5	white	38	51	0.455994	0.254944	1	0	0	no	0.1	0	dnr after sadm	2	107	11.398438	70	20	37.79688	171.40625	null	null	1.699951	143	7.389648	107	31	null	null	6	<2 mo. follow-up	6	10	1
42.74597	male	0	9	Cirrhosis	COPD/CHF/Cirrhosis	3	16	>$50k	0	11,712	5,439.4219	8,912.85938	10	white	19.5	33	0.842896	0.74292	1	0	0	yes	0.95	0.75	no dnr	9	85	3.599609	72	16	37.39844	null	3.599609	0.899902	0.899902	137	null	114	9	3,200	0	0	no(M2 and SIP pres)	0	998	0
82.70496	female	0	7	COPD	COPD/CHF/Cirrhosis	4	12	under $11k	0	7,815	3,563.9981	5,032.76953	5.5	white	17.097656	29	0.80896	0.690918	1	0	0	no	0.5	0.3	no dnr	7	103	6.799805	100	25	36.69531	229.625	null	null	1.199951	137	7.379883	92	24	1,575	1	null	no(M2 and SIP pres)	1.166748	473	1
65.10095	female	0	12	ARF/MOSF w/Sepsis	ARF/MOSF	0	15	under $11k	0	19,496	11,600.2734	7,061.74609	17.5	hispanic	18.597656	14	0.869995	0.824951	1	0	0	no	0.95	0.95	no dnr	12	120	10.099609	51	26	37.89844	242.84375	3.199707	0.299988	1.599854	149	7.459961	86	44	null	0	null	null	0.494751	518	1
77.68097	female	0	7	COPD	COPD/CHF/Cirrhosis	2	12	under $11k	0	7,278	4,078.0527	4,712.27734	6.5	white	13.699219	35	0.872925	0.78894	1	0	0	no	0.8	0.6	dnr before sadm	-1	67	10.5	80	20	36.09375	256	3.299805	null	1.599854	140	7.459961	95	23	5,000	null	2	<2 mo. follow-up	2	26	1
47.12097	male	0	8	Cirrhosis	COPD/CHF/Cirrhosis	2	11	under $11k	0	18,732	7,620.1289	14,185.4062	24.5	white	29.5	44	0.707886	0.547974	1	0	0	no	0.77	0.8	no dnr	8	107	7.299805	100	25	38.89844	null	4.399414	0.899902	0.799927	136	null	197	13	1,950	0	2	SIP>=30	2	212	1
50.60098	male	0	4	COPD	COPD/CHF/Cirrhosis	2	null	null	0	5,799	3,000.6602	3,188.38867	15	white	14.398438	8	0.945923	0.906982	1	0	0	no	0.9	0.85	no dnr	4	65	9.398438	72	8	36.59375	197.5	2.799805	0.399963	1	137	7.369141	132	49	1,020	null	null	null	2.116211	996	0
89.70795	female	1	4	Coma	Coma	3	12	under $11k	44	4,730	2,593.6152	2,530.62891	11	white	26.199219	41	0.11499	0.070999	1	1	1	yes	null	null	dnr before sadm	-1	93	10.199219	80	20	36.09375	285.6875	null	null	1.299805	143	7.40918	109	31	575	null	null	<2 mo. follow-up	5.073242	4	1
44.58899	male	0	13	ARF/MOSF w/Sepsis	ARF/MOSF	3	14	$11-$25k	0	43,026	29,745.9531	30,139.8594	36.5	white	22.699219	41	0.87793	0.834961	1	0	0	no	0.85	0.8	no dnr	13	102	5.299805	73	30	37.59375	176.65625	null	0.299988	1	134	7.369141	508	26	1,760	null	0	no(M2 and SIP pres)	0	67	1
23.33499	female	1	22	MOSF w/Malig	ARF/MOSF	3	13	under $11k	0	118,566	40,615.4688	68,099	44.333313	white	33.398438	59	0.539917	0.424988	1	0	0	yes	0.9	0.6	dnr after sadm	21	47	6.599609	120	35	36.69531	null	null	null	1.299805	138	null	99	21	null	null	0	<2 mo. follow-up	0	22	1
57.629	female	0	17	Cirrhosis	COPD/CHF/Cirrhosis	2	12	$11-$25k	0	36,754	14,798.7344	21,377.7344	30.666656	white	41.398438	40	0.28894	0.11499	1	0	0	no	0.5	0.35	no dnr	17	58	21.199219	99	24	37	132.5	null	0.5	0.799927	137	7.329102	230	10	1,990	null	0	no(M2 and SIP pres)	0	994	0
83.75397	female	0	11	ARF/MOSF w/Sepsis	ARF/MOSF	2	null	null	100	21,739	7,108.4688	17,372.0938	28.5	white	20.199219	33	0.387939	0.268982	1	1	1	no	0.8	0.5	no dnr	11	113	null	68	20	36.19531	null	null	null	null	140	null	null	null	1,100	null	null	null	6.509766	128	1
44.64297	male	0	14	CHF	COPD/CHF/Cirrhosis	2	12	under $11k	0	39,916	29,562.3125	26,730.5781	27.333328	black	33.59375	45	0.751953	0.60791	1	0	0	no	0.5	0.5	no dnr	14	97	6.099609	64	16	36.69531	null	null	0.899902	1.299805	141	null	189	16	null	7	4	<2 mo. follow-up	4	39	1
89.23999	female	0	6	CHF	COPD/CHF/Cirrhosis	3	14	under $11k	0	5,975	3,379.2207	3,369.35938	6	white	14.699219	35	0.810913	0.692993	1	0	0	yes	0.95	0.9	dnr before sadm	-1	55	25.796875	139	26	39.29688	67	1.899902	0.799927	0.899902	144	7.319336	72	42	1,193	0	0	SIP>=30	0	666	1
40.73599	male	0	11	Cirrhosis	COPD/CHF/Cirrhosis	2	null	null	0	20,281	9,646.7969	11,787.3359	13	white	22.796875	50	0.835938	0.731934	2	0	0	no	0.5	0.3	no dnr	11	43	80	50	20	37.79688	null	3	0.599976	2.5	139	null	100	115	625	null	null	null	2.804688	991	0
89.5	female	0	7	ARF/MOSF w/Sepsis	ARF/MOSF	1	12	under $11k	0	14,752	8,761.9141	8,936.48438	13	white	22.898438	33	0.730957	0.647949	1	0	0	no	0.8	0.7	no dnr	7	71	5.299805	110	21	37.5	null	3.399902	3.799805	1	138	null	92	20	1,850	2	2	no(M2 and SIP pres)	2	990	0
83.98395	female	0	7	ARF/MOSF w/Sepsis	ARF/MOSF	5	8	under $11k	0	13,372	8,229.1406	8,197.4375	13	white	20.796875	36	0.787964	0.718994	1	0	1	no	0.25	0.2	dnr after sadm	2	59	10.398438	68	26	36.39844	320	3.699707	0.799927	1.099854	134	7.30957	103	19	2,030	null	null	no(M2 and SIP pres)	6.015625	989	0
77.92694	female	0	17	ARF/MOSF w/Sepsis	ARF/MOSF	0	9	under $11k	0	25,184	17,107.1406	10,980.3984	15.666664	white	24.097656	47	0.757935	0.681885	1	0	0	no	0.75	0.75	no dnr	17	122	6.699219	76	16	36.89844	151.65625	4.099609	null	1.099854	140	7.459961	96	18	3,570	1	0	no(M2 and SIP pres)	0	684	1
64.28198	female	0	12	ARF/MOSF w/Sepsis	ARF/MOSF	2	12	under $11k	0	18,119	9,395.9844	9,250.41406	12.5	white	23.597656	45	0.814941	0.75293	1	1	0	no	0.9	0.9	no dnr	12	109	13	100	34	37.69531	251.84375	3.799805	null	1.099854	137	7.329102	250	34	1,100	1	1	SIP>=30	1	986	0
61.823	female	0	42	Coma	Coma	0	18	>$50k	100	73,012	27,574.4219	58,063.625	31.25	hispanic	23.796875	42	0.241974	0.175995	1	0	0	no	0.3	0.3	no dnr	42	52	1.099854	64	30	36.29688	null	2.5	7.899414	0.599976	139	null	110	15	1,040	null	0	Coma or Intub	0	315	1
28.25999	female	0	10	ARF/MOSF w/Sepsis	ARF/MOSF	1	11	null	0	30,418	13,484.6328	19,141.8281	20.5	white	28.5	25	0.826904	0.768921	6	0	0	no	0.9	0.9	no dnr	10	83	5.699219	60	20	35.59375	239.125	4	0.5	0.899902	138	7.369141	171	11	null	5	0	no(M2 and SIP pres)	0	984	0
83.11798	female	0	18	ARF/MOSF w/Sepsis	ARF/MOSF	3	12	under $11k	0	24,810	11,643.9219	15,341.6094	18.333328	white	34.796875	62	0.481995	0.363953	1	1	0	no	0.5	0.4	no dnr	18	77	26.097656	60	32	36.09375	361.875	3.299805	1.299805	2.399902	145	7.489258	330	37	null	0	0	SIP>=30	0	97	1
59.41998	female	0	9	Colon Cancer	Cancer	1	19	under $11k	0	14,652	7,374.5117	8,592.04688	4	white	22.296875	26	0.746948	0.484985	1	0	0	metastatic	1	0.8	no dnr	9	57	13.199219	120	12	39.19531	266	4.699219	0.399963	0.799927	138	7.399414	129	8	1,180	0	0	no(M2 and SIP pres)	0	785	1
67.06396	female	0	14	ARF/MOSF w/Sepsis	ARF/MOSF	2	14	under $11k	0	36,505	24,395.2812	24,018.8594	24	white	31.097656	42	0.671997	0.575928	1	0	0	no	0.85	0.8	no dnr	14	126	8.199219	134	25	38.09375	152	3.399902	2	3.399902	130	7.389648	167	58	1,971	null	1	no(M2 and SIP pres)	1	982	0
78.94598	male	0	20	ARF/MOSF w/Sepsis	ARF/MOSF	2	null	null	0	67,914	41,837.125	44,909.9375	31.666656	white	39.5	50	0.323975	0.209991	3	1	0	no	0.7	0.343	no dnr	20	48	15.298828	106	8	36.19531	113.75	2.5	6.299805	1.399902	149	7.469727	165	18	2,235	null	null	null	2.676758	552	1
43.42499	male	0	6	CHF	COPD/CHF/Cirrhosis	4	11	under $11k	0	6,695	3,467.9668	3,603.33984	14	black	23.199219	10	0.886963	0.81189	1	0	0	no	0.95	0.9	no dnr	6	51	14.798828	68	8	38.59375	262.5	2.699707	0.299988	0.899902	140	7.40918	321	26	1,080	3	null	SIP>=30	2.510742	980	0
46.80099	male	0	18	Cirrhosis	COPD/CHF/Cirrhosis	2	16	under $11k	9	26,374	14,535.5391	14,160.9844	12	white	37.5	56	0.474976	0.272949	1	0	0	no	0.5	0.3	dnr after sadm	15	66	7.899414	108	26	35.89844	286.625	2.399902	null	1.799805	126	7.5	184	45	2,500	3	null	<2 mo. follow-up	2.510742	55	1
71.31799	male	0	9	Cirrhosis	COPD/CHF/Cirrhosis	3	12	$11-$25k	0	12,882	6,878.3906	6,728.38672	6	white	20.5	33	0.708984	0.54895	1	1	0	no	0.5	0.5	dnr before sadm	0	93	5.599609	60	15	36.09375	318.3125	4.399414	null	2	139	7.359375	108	34	370	0	0	no(M2 and SIP pres)	0	135	1
62.29398	female	0	20	COPD	COPD/CHF/Cirrhosis	4	null	null	0	34,399	15,657.6719	22,460.75	14.333328	white	21.597656	19	0.859985	0.768921	1	0	0	no	0.88	0.77	dnr before sadm	-1	67	16.796875	80	20	38.39844	null	2	15.599609	1.5	142	null	65	33	1,370	null	null	null	3.70459	78	1
41.008	male	0	7	Cirrhosis	COPD/CHF/Cirrhosis	4	15	under $11k	0	16,407	7,312.7578	10,987.6875	8	white	17.898438	34	0.893921	0.822998	1	0	0	no	0.9	0.7	no dnr	7	110	5.899414	60	16	36.19531	297.125	4.699219	0.599976	2.299805	144	7.419922	107	45	1,795	0	null	no(M2 and SIP pres)	0.494751	974	0
53.03198	male	0	10	ARF/MOSF w/Sepsis	ARF/MOSF	0	20	$25-$50k	0	19,707	7,497.7969	13,036.8125	23.5	white	22.5	40	0.849976	0.79895	2	0	0	no	0.95	0.95	no dnr	10	62	7.199219	42	16	36.09375	319	null	null	1.5	139	7.379883	125	35	1,170	0	0	no(M2 and SIP pres)	0	973	0
95.60596	female	0	8	ARF/MOSF w/Sepsis	ARF/MOSF	1	4	null	0	10,736	4,586.8047	7,526.32812	10.5	white	25.296875	19	0.578979	0.467957	1	0	0	yes	0.5	0.4	dnr before sadm	-1	74	10.398438	62	10	38.09375	373.3125	2.799805	0.5	5.699219	132	7.229492	104	78	1,510	0	1	no(M2 and SIP pres)	1	972	0
62.88599	female	0	4	ARF/MOSF w/Sepsis	ARF/MOSF	1	16	$25-$50k	9	12,771	4,837.4727	7,684.82812	14	white	20.898438	30	0.833984	0.776978	1	0	0	no	0.8	0.7	no dnr	4	127	10.298828	120	35	40	204.75	3.399902	0.599976	1.099854	139	7.429688	151	12	2,300	0	4	no(M2 and SIP pres)	4	332	1
62.12698	female	0	23	ARF/MOSF w/Sepsis	ARF/MOSF	1	14	$25-$50k	0	52,812	38,622.9062	38,980.4062	33.666657	hispanic	18.796875	23	0.865967	0.819946	2	1	0	no	0.8	0.6	no dnr	23	153	14.599609	125	36	39.59375	438.0625	2.899902	null	1.199951	134	7.5	220	16	1,055	null	0	adl>=4 (>=5 if sur)	0	971	0
50.82498	female	0	7	ARF/MOSF w/Sepsis	ARF/MOSF	2	12	null	0	23,926	13,897.9531	14,176.3047	6.5	black	28.398438	29	0.684937	0.591919	7	0	0	yes	0.65	0.35	dnr before sadm	0	111	14	110	44	37.89844	136.65625	null	null	0.599976	141	7.399414	93	18	3,400	2	6	<2 mo. follow-up	6	49	1
77.26495	male	1	11	ARF/MOSF w/Sepsis	ARF/MOSF	2	8	$11-$25k	37	28,082	10,635.9766	24,002.6562	38.5	white	40	63	0.184998	0.095993	1	0	0	no	0.3	0.3	dnr after sadm	5	55	12.398438	114	30	38.69531	136.71875	3.799805	0.699951	2.699707	136	7.459961	262	61	1,156	null	4	<2 mo. follow-up	4	11	1
44.92297	female	1	9	MOSF w/Malig	ARF/MOSF	1	16	$11-$25k	0	23,066	7,157.0508	19,547.0938	39	white	29.097656	48	0.536987	0.421997	1	0	0	metastatic	0.3	0.1	dnr after sadm	7	103	16.296875	120	25	38.89844	null	null	null	0.799927	135	null	154	11	1,795	null	null	<2 mo. follow-up	2.438477	9	1
49.85397	male	1	7	MOSF w/Malig	ARF/MOSF	1	24	>$50k	0	39,151	16,444.9531	22,753.8125	39.5	white	28.796875	46	0.457947	0.338989	6	0	0	metastatic	0.25	0.15	dnr after sadm	5	57	11.798828	120	26	39.19531	128	2.799805	0.599976	0.799927	133	7.419922	128	9	2,279	null	0	<2 mo. follow-up	0	7	1
88.81598	female	0	4	ARF/MOSF w/Sepsis	ARF/MOSF	4	8	under $11k	9	8,938	4,971.3711	4,022.48828	13	white	22.796875	19	0.704956	0.615967	1	1	1	no	0.8	0.5	no dnr	4	43	17.296875	130	14	38.69531	140	null	null	1.799805	136	7.30957	189	27	1,300	null	null	adl>=4 (>=5 if sur)	6.263672	965	0
90.76794	female	0	15	COPD	COPD/CHF/Cirrhosis	1	12	under $11k	0	27,955	10,796.5703	23,236.2188	21.333328	white	19.398438	41	0.712891	0.553955	1	0	0	no	0.5	0.4	dnr after sadm	3	80	6.399414	80	20	35.59375	347.5625	2.299805	0.799927	1.199951	139	7.369141	113	14	3,400	null	2	adl>=4 (>=5 if sur)	2	742	1
94.07495	female	0	10	ARF/MOSF w/Sepsis	ARF/MOSF	2	null	under $11k	0	13,122	7,737.0781	3,572.13867	18	white	26.097656	25	0.640991	0.53894	1	0	1	no	0.7	0.5	dnr after sadm	1	50	13.599609	110	20	36.09375	null	2.199707	11.298828	0.699951	130	null	157	13	850	null	1	null	1	726	1
61.91397	female	1	22	ARF/MOSF w/Sepsis	ARF/MOSF	2	9	$11-$25k	0	69,577	26,139.0625	48,763.75	37	white	24.898438	61	0.751953	0.672974	9	0	0	no	0.3	0.3	dnr after sadm	18	73	2.799805	80	20	36.09375	null	2	3.5	0.699951	131	null	294	13	null	null	7	<2 mo. follow-up	7	22	1
68.60797	female	0	19	ARF/MOSF w/Sepsis	ARF/MOSF	0	13	>$50k	0	85,343	46,375.0312	59,210.5	23	white	23.898438	53	0.744995	0.664917	8	0	0	no	0.8	0.8	no dnr	19	100	12.398438	108	32	36.59375	225.6875	null	null	0.699951	141	7.379883	202	10	2,280	null	0	null	0	961	0
62.327	male	1	4	Lung Cancer	Cancer	2	null	null	0	4,703	2,592.9492	2,374.42969	9	white	39.09375	37	0.131989	0.007	1	1	0	metastatic	0.05	0.01	dnr before sadm	-1	57	8.199219	74	24	37.79688	null	null	null	1.299805	130	null	169	39	900	null	null	<2 mo. follow-up	2.736328	4	1
77.86694	female	1	4	ARF/MOSF w/Sepsis	ARF/MOSF	4	8	under $11k	41	7,696	3,119.4824	7,546.54688	33	white	44.898438	80	0.031998	0.007999	1	1	0	yes	0.1	0.07	dnr after sadm	2	60	8.798828	52	50	38.79688	171	2.599609	0.699951	0.899902	141	7.369141	96	14	3,450	null	null	<2 mo. follow-up	3.519531	4	1
32.84598	female	0	30	ARF/MOSF w/Sepsis	ARF/MOSF	1	null	under $11k	0	79,142	31,164.3906	49,507.875	27.75	hispanic	21.796875	29	0.896973	0.858887	3	0	0	no	0.9	0.9	no dnr	30	100	12.898438	70	20	35.89844	357.125	3.799805	1.099854	0.699951	125	7.509766	237	14	null	null	0	no(M2 and SIP pres)	0	956	0
70.70795	male	0	35	ARF/MOSF w/Sepsis	ARF/MOSF	2	9	$11-$25k	0	165,432	96,053.8125	105,092.812	25.25	white	21.699219	15	0.694946	0.603882	28	0	0	yes	null	null	no dnr	35	105	10.798828	180	20	37.89844	640	3.099609	1.399902	0.799927	143	7.269531	102	6	2,750	0	0	SIP>=30	0	956	0
58.81198	female	0	6	Lung Cancer	Cancer	2	18	null	0	6,654	3,721.7891	4,312.9375	11	white	14.898438	6	0.759888	0.505981	1	0	0	metastatic	0.95	0.75	no dnr	6	117	11.5	80	9	39.29688	185	null	null	1.299805	144	7.489258	110	15	1,273	0	0	no(M2 and SIP pres)	0	152	1
74.11096	female	0	48	ARF/MOSF w/Sepsis	ARF/MOSF	1	14	null	9	99,474	24,398.5625	97,995.375	26.5	white	41.296875	48	0.276978	0.168976	2	0	0	no	0.9	0.7	no dnr	48	83	3	100	20	36.69531	null	null	null	3.5	142	null	70	66	1,100	null	7	adl>=4 (>=5 if sur)	7	954	0
65.89197	female	0	5	MOSF w/Malig	ARF/MOSF	3	12	under $11k	0	13,944	4,423.6641	10,383.3125	33	white	26.597656	26	0.616943	0.512939	2	1	0	yes	null	null	no dnr	5	109	24.199219	113	24	36.39844	356	1.599854	26.796875	3.899902	150	7.419922	153	147	1,600	null	null	<2 mo. follow-up	2.152832	39	1
83.40295	male	0	18	CHF	COPD/CHF/Cirrhosis	2	null	null	0	44,009	24,023.8906	27,881.1719	24	white	19.398438	34	0.807983	0.688965	1	0	0	no	0.9	0.75	no dnr	18	54	9.5	145	12	38.79688	161.65625	2.599609	0.299988	0.699951	153	7.349609	144	26	3,155	null	null	null	3.135254	140	1
72.099	female	0	3	ARF/MOSF w/Sepsis	ARF/MOSF	1	14	null	0	6,312	1,674.8115	6,128.40625	null	white	19.097656	36	0.796997	0.730957	2	0	0	yes	null	null	no dnr	3	54	4.699219	76	28	38.19531	107.5	2.599609	1	0.699951	141	7.439453	221	26	4,745	2	null	adl>=4 (>=5 if sur)	1.838867	98	1
72.81	female	0	6	ARF/MOSF w/Sepsis	ARF/MOSF	3	14	$11-$25k	0	9,466	4,703.8672	6,218.63672	18	white	25.296875	51	0.703979	0.61499	1	1	0	yes	0.85	0.65	no dnr	6	110	7.699219	70	20	35.89844	114	3.599609	null	1.199951	146	7.259766	90	23	2,631	null	null	no(M2 and SIP pres)	2.320801	858	1
68.99896	female	0	8	Lung Cancer	Cancer	3	16	>$50k	0	11,272	6,130.332	6,395.29688	9.5	white	19.097656	23	0.652954	0.347961	1	0	0	metastatic	0.5	0.2	no dnr	8	137	7	56	50	37.89844	293.3125	null	null	0.799927	141	7.399414	166	20	1,610	2	2	<2 mo. follow-up	2	32	1
89.46997	male	0	14	ARF/MOSF w/Sepsis	ARF/MOSF	1	10	>$50k	0	43,497	23,069.7344	24,701.7969	10	white	25.699219	32	0.616943	0.511963	5	0	0	no	0.7	0.7	dnr after sadm	1	97	10.398438	60	20	36.09375	131.65625	null	null	1.599854	143	7.30957	94	40	1,600	null	1	no(M2 and SIP pres)	1	611	1
45.741	male	0	23	Coma	Coma	3	8	under $11k	0	35,265	16,548.5625	24,172.3594	22.333328	white	23.699219	50	0.807983	0.770996	1	1	1	no	0.5	0.5	no dnr	23	139	10.599609	104	60	38.29688	297.5	2	0.299988	7.299805	140	7.359375	121	69	1,150	null	7	adl>=4 (>=5 if sur)	7	121	1
62.11899	male	0	9	COPD	COPD/CHF/Cirrhosis	3	17	$25-$50k	0	12,604	6,835.1055	7,271.77734	11	white	19.097656	17	0.855957	0.762939	1	0	0	yes	0.95	0.95	no dnr	9	55	12.398438	72	24	36.69531	240	3.399902	null	2.199707	145	7.529297	105	43	3,990	1	1	no(M2 and SIP pres)	1	947	0
86.75995	female	0	102	ARF/MOSF w/Sepsis	ARF/MOSF	1	8	under $11k	9	108,592	62,537.4062	64,422.0312	12.25	white	24	44	0.688965	0.596924	1	0	1	no	0.6	0.6	dnr after sadm	12	73	4.399414	130	30	36.09375	null	2	null	1.099854	145	null	281	25	null	null	2	null	2	238	1
82.12994	female	0	17	COPD	COPD/CHF/Cirrhosis	4	8	under $11k	0	44,671	14,975.4922	39,899.2188	19	white	37.195313	55	0.232971	0.078995	14	0	0	no	0.75	0.66	dnr after sadm	6	39	13.599609	125	34	38.39844	148.96875	3.099609	1.399902	2.599609	136	7.359375	110	94	107	2	1	<2 mo. follow-up	1	52	1
64.01398	female	0	10	COPD	COPD/CHF/Cirrhosis	2	12	under $11k	0	12,940	7,034.8008	6,696.66797	12.5	black	20.199219	30	0.866943	0.778931	1	0	0	no	0.9	0.8	no dnr	10	121	10.898438	106	12	38.29688	157	null	0.299988	0.799927	143	7.399414	145	12	1,625	2	1	no(M2 and SIP pres)	1	944	0
41.66498	male	0	23	ARF/MOSF w/Sepsis	ARF/MOSF	4	12	null	0	71,676	39,046.6875	38,814.4688	33	black	36.898438	47	0.608887	0.50293	7	1	0	no	0.8	0.8	no dnr	23	107	6.599609	110	10	39.19531	190	null	null	1.199951	149	7.439453	136	18	4,890	null	0	no(M2 and SIP pres)	0	943	0
73.599	male	1	52	MOSF w/Malig	ARF/MOSF	1	16	$11-$25k	0	179,085	108,960	103,456.438	31.5	white	21.796875	34	0.56897	0.45697	20	0	0	metastatic	0.95	0.7	dnr after sadm	39	81	6.799805	76	20	37.39844	null	null	null	0.599976	137	null	115	10	4,202	null	0	<2 mo. follow-up	0	52	1
76.08795	male	0	22	ARF/MOSF w/Sepsis	ARF/MOSF	1	11	null	0	45,370	20,808.0156	30,189.3906	27.333328	black	19.597656	35	0.829956	0.772949	1	0	0	no	0.85	0.6	dnr after sadm	7	47	5.799805	60	42	36.09375	80	2.899902	0.399963	0.299988	141	7.399414	102	3	3,195	null	0	<2 mo. follow-up	0	34	1

Subsets and Splits

No community queries yet

The top public SQL queries from the community will appear here once available.